We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App

Biology-Driven Radiomics Approach to Identify Rectal Cancer Patients without Tumor Post Therapy

By MedImaging International staff writers
Posted on 25 Jun 2024
Print article
Image: The researchers will use AI to derive specific metrics from MRI scans to analyze the therapeutic response of rectal tumors more effectively (Photo courtesy of Shutterstock)
Image: The researchers will use AI to derive specific metrics from MRI scans to analyze the therapeutic response of rectal tumors more effectively (Photo courtesy of Shutterstock)

The American Cancer Society estimates that this year, around 46,000 people in the U.S. will be diagnosed with rectal cancer, which ranks as the third most common type of cancer in the digestive system, following colon and pancreatic cancers. For rectal cancer patients undergoing chemotherapy and radiation, clinicians often encounter challenges in determining which tumors are dying or significantly regressing post-therapy. Researchers are now planning to use artificial intelligence (AI) to improve the treatment of rectal cancer patients by accurately assessing their response to therapy, thus enabling personalized care through the selection of suitable candidates for non-operative management.

A research group, including experts from Case Western Reserve University (CWRU, Cleveland, OH, USA), has secured a five-year, USD 2.78 million grant from the National Institutes of Health and the National Cancer Institute to better personalize treatments for patients with rectal cancer. They plan to use AI to derive specific metrics from magnetic resonance imaging (MRI) scans to analyze the therapeutic response of rectal tumors more effectively. This investigation will utilize AI to examine medical images from over 900 patients with rectal cancer, applying a novel, biology-driven radiomics method, and will also incorporate data from a prior clinical trial involving patients with this disease.

The researchers will evaluate how effectively patients are responding to treatment using the insights obtained through this analysis. Their objective is to establish a non-invasive and precise technique for identifying patients who show no remaining tumor after therapy, thereby reducing unnecessary surgical interventions and their related complications. This research holds significant promise for identifying signs of tumor regression, exploring traits that typically remain undetected by human observation alone. Additionally, the team plans to integrate AI analysis with clinical assessments to develop ways to incorporate AI-derived insights into regular clinical practices.

“Our goal is to develop new types of radiomic signatures, involving computational analysis of radiology and pathology images, to determine how well these patients have responded to therapy,” said Satish Viswanath, an associate professor of biomedical engineering at Case Western Reserve and the grant’s lead researcher. “By doing so, doctors will be able to better personalize treatments for patients with rectal cancer.”

Related Links:

Gold Member
Solid State Kv/Dose Multi-Sensor
Endoscopic Ultrasound Fine Needle Biopsy Device
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
NMUS & MSK Ultrasound
InVisus Pro

Print article



view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Calantic Digital Solutions is an orchestrated suite of AI radiology solutions that aims to transform radiology (Photo courtesy of Bayer)

Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions

Imaging data constitutes approximately 90% of all medical data, with the volume of such data continuously expanding, thereby significantly increasing the workload for radiologists amid existing resource limitations.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.